CLINICAL_TRIALS
trial_result
· 2016-03-09
Clinical Trial Update: A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma [Phase 2]
Summary
Phase 2 dose-escalation trial evaluating collagenase clostridium histolyticum for treating lipoma. Results were posted in March 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zachary Gerut | Conditions: Lipoma | Phase 2 | Status: COMPLETED | Results posted: 2016-03-09